In this segment, we discussed the recent American Heart Association guidance on LDL cholesterol and the sobering estimate that only about one in three adults has their cholesterol adequately managed. For patients with risk factors for cardiovascular disease, the LDL target is now 55 mg/dL or lower — a number that is all too often overlooked when lab results are reviewed. The result is that many people are walking around with elevated LDL cholesterol, unaware that they are at meaningful risk for serious cardiovascular events including heart attack, stroke, and heart failure.
The call to action for listeners is straightforward: log into your hospital or clinic patient portal, pull up your most recent lipid panel, and confirm that your LDL cholesterol is in range. Diet and exercise absolutely play a role in improving LDL, but lifestyle change alone is frequently not enough — particularly for patients with diabetes, hypertension, obesity, or fatty liver disease. In these cases, statin therapy is often the necessary next step, and it should not be viewed as a failure of lifestyle effort but as appropriate risk reduction.
We also covered two additional recommendations. First, the AHA now advises a one-time measurement of lipoprotein(a). An elevated Lp(a) signals a substantially higher cardiovascular risk, and because the level is genetically determined, it typically will not improve with diet or exercise — making it essential information for guiding how aggressively other risk factors are treated. Second, a coronary calcium scan can bring your individual risk into sharp focus. A positive calcium score is a clear indication that aggressive intervention is warranted. Taken together, these three steps — knowing your LDL, checking your Lp(a) once, and considering a calcium score — give you and your clinician a far more complete picture of your true cardiovascular risk.
","author_name":"Dr Joe Galati"}